APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dental Drug

There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.

Selected research

Market Outlook & Growth Opportunities

Global Dental Drug Market Outlook and Growth Opportunities 2026

21 December 2025205 pages

Choose your research edition.

Industry ResearchDental Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Dental Drug Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Dental Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dental Drug Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Dental Drug Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

There are a number of different drugs that dentist may prescribe, depending on patient’s condition. Some medications are prescribed to fight certain oral diseases, to prevent or treat infections, or to control pain and relieve anxiety. The dose of the drugs and instructions on how to take them will differ from patient to patient, depending on what the drug is being used for, patient's age, weight, and other considerations.

Global Dental Drug key players include Merck, Bayer, JandJ, GSK, 3M, etc. Global top five players hold a share about 40%.

North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, having a total share about 55 percent.

Read the full market overview

In terms of product, OTC is the largest segment, with a share about 60%. And in terms of application, the largest application is Hospitals, followed by Dental Clinics, Drugstores.

This report provides an overview of the global Dental Drug market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dental Drug and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dental Drug revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Dental Drug market.

Dental Drug Segment by Company

Merck

Bayer

JandJ

GSK

3M

Sunstar

Colgate-Palmolive

DenMat

Showa Yakuhin Kako

Bausch Health

Septodont

Roche

PerioChip

Hutchison China MediTech

Xiuzheng Pharmaceutical

Acteon

Xttrium Laboratorie

Mediwin Pharmaceuticals

Dental Drug Segment by Type

OTC

Prescription Product

Dental Drug Segment by Application

Hospitals

Dental Clinics

Drugstores

Dental Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dental Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Dental Drug key companies, revenue, market share, and recent developments.

3. To split the Dental Drug breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Dental Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dental Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Dental Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dental Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dental Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dental Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dental Drug industry.

Chapter 3: Detailed analysis of Dental Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Dental Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Dental Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dental Drug Industry Trends Table 2. Dental Drug Industry Drivers Table 3. Dental Drug Industry Opportunities and Challenges Table 4. Dental Drug Industry Restraints Table 5. Global Dental Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dental Drug Revenue Share by Company (2021-2026) Table 7. Global Dental Drug Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Dental Drug Key Company Manufacturing Base & Headquarters Table 9. Global Dental Drug Company, Product Type & Application Table 10. Global Dental Drug Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Dental Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of OTC Table 15. Significant Companies of Prescription Product Table 16. Global Dental Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Dental Drug Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Dental Drug Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Dental Drug Sales Value Share by Type (2021-2026) Table 20. Global Dental Drug Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Dental Clinics Table 23. Significant Companies of Drugstores Table 24. Global Dental Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dental Drug Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Dental Drug Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Dental Drug Sales Value Share by Application (2021-2026) Table 28. Global Dental Drug Sales Value Share by Application (2027-2032) Table 29. Global Dental Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Dental Drug Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Dental Drug Sales Value Share by Region (2021-2026) Table 32. Global Dental Drug Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Dental Drug Sales Value Share by Region (2027-2032) Table 34. Global Dental Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Dental Drug Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Dental Drug Sales Value Market Share by Country (2021-2026) Table 37. Global Dental Drug Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Dental Drug Sales Value Market Share by Country (2027-2032) Table 39. Merck Company Information Table 40. Merck Business Overview Table 41. Merck Dental Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Merck Dental Drug Product Portfolio Table 43. Merck Recent Development Table 44. Bayer Company Information Table 45. Bayer Business Overview Table 46. Bayer Dental Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Bayer Dental Drug Product Portfolio Table 48. Bayer Recent Development Table 49. JandJ Company Information Table 50. JandJ Business Overview Table 51. JandJ Dental Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. JandJ Dental Drug Product Portfolio Table 53. JandJ Recent Development Table 54. GSK Company Information Table 55. GSK Business Overview Table 56. GSK Dental Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. GSK Dental Drug Product Portfolio Table 58. GSK Recent Development Table 59. 3M Company Information Table 60. 3M Business Overview Table 61. 3M Dental Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. 3M Dental Drug Product Portfolio Table 63. 3M Recent Development Table 64. Sunstar Company Information Table 65. Sunstar Business Overview Table 66. Sunstar Dental Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sunstar Dental Drug Product Portfolio Table 68. Sunstar Recent Development Table 69. Colgate-Palmolive Company Information Table 70. Colgate-Palmolive Business Overview Table 71. Colgate-Palmolive Dental Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Colgate-Palmolive Dental Drug Product Portfolio Table 73. Colgate-Palmolive Recent Development Table 74. DenMat Company Information Table 75. DenMat Business Overview Table 76. DenMat Dental Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. DenMat Dental Drug Product Portfolio Table 78. DenMat Recent Development Table 79. Showa Yakuhin Kako Company Information Table 80. Showa Yakuhin Kako Business Overview Table 81. Showa Yakuhin Kako Dental Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Showa Yakuhin Kako Dental Drug Product Portfolio Table 83. Showa Yakuhin Kako Recent Development Table 84. Bausch Health Company Information Table 85. Bausch Health Business Overview Table 86. Bausch Health Dental Drug Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Bausch Health Dental Drug Product Portfolio Table 88. Bausch Health Recent Development Table 89. Septodont Company Information Table 90. Septodont Business Overview Table 91. Septodont Dental Drug Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 92. Septodont Dental Drug Product Portfolio Table 93. Septodont Recent Development Table 94. Roche Company Information Table 95. Roche Business Overview Table 96. Roche Dental Drug Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 97. Roche Dental Drug Product Portfolio Table 98. Roche Recent Development Table 99. PerioChip Company Information Table 100. PerioChip Business Overview Table 101. PerioChip Dental Drug Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 102. PerioChip Dental Drug Product Portfolio Table 103. PerioChip Recent Development Table 104. Hutchison China MediTech Company Information Table 105. Hutchison China MediTech Business Overview Table 106. Hutchison China MediTech Dental Drug Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 107. Hutchison China MediTech Dental Drug Product Portfolio Table 108. Hutchison China MediTech Recent Development Table 109. Xiuzheng Pharmaceutical Company Information Table 110. Xiuzheng Pharmaceutical Business Overview Table 111. Xiuzheng Pharmaceutical Dental Drug Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 112. Xiuzheng Pharmaceutical Dental Drug Product Portfolio Table 113. Xiuzheng Pharmaceutical Recent Development Table 114. Acteon Company Information Table 115. Acteon Business Overview Table 116. Acteon Dental Drug Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 117. Acteon Dental Drug Product Portfolio Table 118. Acteon Recent Development Table 119. Xttrium Laboratorie Company Information Table 120. Xttrium Laboratorie Business Overview Table 121. Xttrium Laboratorie Dental Drug Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 122. Xttrium Laboratorie Dental Drug Product Portfolio Table 123. Xttrium Laboratorie Recent Development Table 124. Mediwin Pharmaceuticals Company Information Table 125. Mediwin Pharmaceuticals Business Overview Table 126. Mediwin Pharmaceuticals Dental Drug Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 127. Mediwin Pharmaceuticals Dental Drug Product Portfolio Table 128. Mediwin Pharmaceuticals Recent Development Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Dental Drug Product Image Figure 2. Global Dental Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dental Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Dental Drug Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. OTC Image Figure 8. Prescription Product Image Figure 9. Global Dental Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Dental Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Dental Drug Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Dental Clinics Image Figure 14. Drugstores Image Figure 15. Global Dental Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Dental Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Dental Drug Sales Value Share by Application (2021-2032) Figure 18. Global Dental Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Dental Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Dental Drug Sales Value (2021-2032) & (US$ Million) Figure 21. North America Dental Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Dental Drug Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Dental Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Dental Drug Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Dental Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Dental Drug Sales Value (2021-2032) & (US$ Million) Figure 27. South America Dental Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Dental Drug Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Dental Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Dental Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Dental Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Dental Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • Prescription Product
Applications
  • Hospitals
  • Dental Clinics
  • Drugstores
Companies covered
  • Merck
  • Bayer
  • JandJ
  • GSK
  • 3M
  • Sunstar
  • Colgate-Palmolive
  • DenMat
  • Showa Yakuhin Kako
  • Bausch Health
  • Septodont
  • Roche
  • PerioChip
  • Hutchison China MediTech
  • Xiuzheng Pharmaceutical
  • Acteon
  • Xttrium Laboratorie
  • Mediwin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Dental Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Dental Drug Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Dental Drug Market Dynamics
  1. 2.1 Dental Drug Industry Trends
  2. 2.2 Dental Drug Industry Drivers
  3. 2.3 Dental Drug Industry Opportunities and Challenges
  4. 2.4 Dental Drug Industry Restraints
3 Dental Drug Market by Company
  1. 3.1 Global Dental Drug Company Revenue Ranking in 2025
  2. 3.2 Global Dental Drug Revenue by Company (2021-2026)
  3. 3.3 Global Dental Drug Company Ranking (2024-2026)
  4. 3.4 Global Dental Drug Company Manufacturing Base and Headquarters
  5. 3.5 Global Dental Drug Company Product Type and Application
  6. 3.6 Global Dental Drug Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Dental Drug Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Dental Drug Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Dental Drug Market by Type
  1. 4.1 Dental Drug Type Introduction
  2. 4.1.1 OTC
  3. 4.1.2 Prescription Product
  4. 4.2 Global Dental Drug Sales Value by Type
  5. 4.2.1 Global Dental Drug Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dental Drug Sales Value by Type (2021-2032)
  7. 4.2.3 Global Dental Drug Sales Value Share by Type (2021-2032)
5 Dental Drug Market by Application
  1. 5.1 Dental Drug Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Dental Clinics
  4. 5.1.3 Drugstores
  5. 5.2 Global Dental Drug Sales Value by Application
  6. 5.2.1 Global Dental Drug Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dental Drug Sales Value by Application (2021-2032)
  8. 5.2.3 Global Dental Drug Sales Value Share by Application (2021-2032)
6 Dental Drug Regional Value Analysis
  1. 6.1 Global Dental Drug Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dental Drug Sales Value by Region (2021-2032)
  3. 6.2.1 Global Dental Drug Sales Value by Region: 2021-2026
  4. 6.2.2 Global Dental Drug Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Dental Drug Sales Value (2021-2032)
  7. 6.3.2 North America Dental Drug Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Dental Drug Sales Value (2021-2032)
  10. 6.4.2 Europe Dental Drug Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Dental Drug Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Dental Drug Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Dental Drug Sales Value (2021-2032)
  16. 6.6.2 South America Dental Drug Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Dental Drug Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Dental Drug Sales Value Share by Country, 2025 VS 2032
7 Dental Drug Country-level Value Analysis
  1. 7.1 Global Dental Drug Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dental Drug Sales Value by Country (2021-2032)
  3. 7.2.1 Global Dental Drug Sales Value by Country (2021-2026)
  4. 7.2.2 Global Dental Drug Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Dental Drug Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Dental Drug Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Dental Drug Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Dental Drug Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Dental Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Dental Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Dental Drug Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Dental Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Dental Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Dental Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Dental Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Dental Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Dental Drug Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Dental Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Dental Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Dental Drug Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Dental Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Dental Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Dental Drug Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Dental Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Dental Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Dental Drug Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Dental Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Dental Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Dental Drug Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Dental Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Dental Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Dental Drug Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Dental Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Dental Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Dental Drug Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Dental Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Dental Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Dental Drug Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Dental Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Dental Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Dental Drug Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Dental Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Dental Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Dental Drug Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Dental Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Dental Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Dental Drug Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Dental Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Dental Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Dental Drug Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Dental Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Dental Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Dental Drug Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Dental Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Dental Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Dental Drug Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Dental Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Dental Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Dental Drug Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Dental Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Dental Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Dental Drug Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Dental Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Dental Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Dental Drug Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Dental Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Dental Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Dental Drug Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Dental Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Dental Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Dental Drug Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Dental Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Dental Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Dental Drug Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Dental Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Dental Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Dental Drug Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Dental Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Dental Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Dental Drug Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Dental Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Dental Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Dental Drug Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Dental Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Dental Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Dental Drug Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Dental Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Dental Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Dental Drug Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Dental Drug Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Dental Drug Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Dental Drug Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 JandJ
  14. 8.3.1 JandJ Company Information
  15. 8.3.2 JandJ Business Overview
  16. 8.3.3 JandJ Dental Drug Revenue and Gross Margin (2021-2026)
  17. 8.3.4 JandJ Dental Drug Product Portfolio
  18. 8.3.5 JandJ Recent Developments
  19. 8.4 GSK
  20. 8.4.1 GSK Company Information
  21. 8.4.2 GSK Business Overview
  22. 8.4.3 GSK Dental Drug Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GSK Dental Drug Product Portfolio
  24. 8.4.5 GSK Recent Developments
  25. 8.5 3M
  26. 8.5.1 3M Company Information
  27. 8.5.2 3M Business Overview
  28. 8.5.3 3M Dental Drug Revenue and Gross Margin (2021-2026)
  29. 8.5.4 3M Dental Drug Product Portfolio
  30. 8.5.5 3M Recent Developments
  31. 8.6 Sunstar
  32. 8.6.1 Sunstar Company Information
  33. 8.6.2 Sunstar Business Overview
  34. 8.6.3 Sunstar Dental Drug Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sunstar Dental Drug Product Portfolio
  36. 8.6.5 Sunstar Recent Developments
  37. 8.7 Colgate-Palmolive
  38. 8.7.1 Colgate-Palmolive Company Information
  39. 8.7.2 Colgate-Palmolive Business Overview
  40. 8.7.3 Colgate-Palmolive Dental Drug Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Colgate-Palmolive Dental Drug Product Portfolio
  42. 8.7.5 Colgate-Palmolive Recent Developments
  43. 8.8 DenMat
  44. 8.8.1 DenMat Company Information
  45. 8.8.2 DenMat Business Overview
  46. 8.8.3 DenMat Dental Drug Revenue and Gross Margin (2021-2026)
  47. 8.8.4 DenMat Dental Drug Product Portfolio
  48. 8.8.5 DenMat Recent Developments
  49. 8.9 Showa Yakuhin Kako
  50. 8.9.1 Showa Yakuhin Kako Company Information
  51. 8.9.2 Showa Yakuhin Kako Business Overview
  52. 8.9.3 Showa Yakuhin Kako Dental Drug Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Showa Yakuhin Kako Dental Drug Product Portfolio
  54. 8.9.5 Showa Yakuhin Kako Recent Developments
  55. 8.10 Bausch Health
  56. 8.10.1 Bausch Health Company Information
  57. 8.10.2 Bausch Health Business Overview
  58. 8.10.3 Bausch Health Dental Drug Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bausch Health Dental Drug Product Portfolio
  60. 8.10.5 Bausch Health Recent Developments
  61. 8.11 Septodont
  62. 8.11.1 Septodont Company Information
  63. 8.11.2 Septodont Business Overview
  64. 8.11.3 Septodont Dental Drug Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Septodont Dental Drug Product Portfolio
  66. 8.11.5 Septodont Recent Developments
  67. 8.12 Roche
  68. 8.12.1 Roche Company Information
  69. 8.12.2 Roche Business Overview
  70. 8.12.3 Roche Dental Drug Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Roche Dental Drug Product Portfolio
  72. 8.12.5 Roche Recent Developments
  73. 8.13 PerioChip
  74. 8.13.1 PerioChip Company Information
  75. 8.13.2 PerioChip Business Overview
  76. 8.13.3 PerioChip Dental Drug Revenue and Gross Margin (2021-2026)
  77. 8.13.4 PerioChip Dental Drug Product Portfolio
  78. 8.13.5 PerioChip Recent Developments
  79. 8.14 Hutchison China MediTech
  80. 8.14.1 Hutchison China MediTech Company Information
  81. 8.14.2 Hutchison China MediTech Business Overview
  82. 8.14.3 Hutchison China MediTech Dental Drug Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hutchison China MediTech Dental Drug Product Portfolio
  84. 8.14.5 Hutchison China MediTech Recent Developments
  85. 8.15 Xiuzheng Pharmaceutical
  86. 8.15.1 Xiuzheng Pharmaceutical Company Information
  87. 8.15.2 Xiuzheng Pharmaceutical Business Overview
  88. 8.15.3 Xiuzheng Pharmaceutical Dental Drug Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Xiuzheng Pharmaceutical Dental Drug Product Portfolio
  90. 8.15.5 Xiuzheng Pharmaceutical Recent Developments
  91. 8.16 Acteon
  92. 8.16.1 Acteon Company Information
  93. 8.16.2 Acteon Business Overview
  94. 8.16.3 Acteon Dental Drug Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Acteon Dental Drug Product Portfolio
  96. 8.16.5 Acteon Recent Developments
  97. 8.17 Xttrium Laboratorie
  98. 8.17.1 Xttrium Laboratorie Company Information
  99. 8.17.2 Xttrium Laboratorie Business Overview
  100. 8.17.3 Xttrium Laboratorie Dental Drug Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Xttrium Laboratorie Dental Drug Product Portfolio
  102. 8.17.5 Xttrium Laboratorie Recent Developments
  103. 8.18 Mediwin Pharmaceuticals
  104. 8.18.1 Mediwin Pharmaceuticals Company Information
  105. 8.18.2 Mediwin Pharmaceuticals Business Overview
  106. 8.18.3 Mediwin Pharmaceuticals Dental Drug Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Mediwin Pharmaceuticals Dental Drug Product Portfolio
  108. 8.18.5 Mediwin Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst